Towards an arthritis flare-responsive drug delivery system

Area of Science:

• Biomaterials Science
• Rheumatology
• Drug Delivery Systems

Background:

• Local delivery of therapeutics for inflammatory arthritis (IA) faces challenges due to short intra-articular drug half-lives.
• Current IA treatments lack the ability to adjust drug release according to fluctuating disease activity.

Purpose of the Study:

• To develop and evaluate a novel hydrogel platform for controlled, on-demand drug release in response to inflammatory arthritis flares.
• To investigate the potential of this flare-responsive hydrogel as an advanced therapeutic strategy for IA.

Main Methods:

• Development of a hydrogel system designed to disassemble and release drugs based on enzyme concentrations associated with arthritis flares.
• In vitro testing of hydrogel loaded with triamcinolone acetonide (TA) using patient rheumatoid arthritis synovial fluid.
• In vivo assessment in arthritic mice using a fluorescent dye-loaded hydrogel to measure flare-dependent disassembly and evaluating TA-loaded hydrogel efficacy.

Main Results:

• The hydrogel demonstrated on-demand release of triamcinolone acetonide (TA) upon exposure to enzymes and rheumatoid arthritis synovial fluid in vitro.
• In arthritic mice, the hydrogel showed flare-dependent disassembly, indicated by loss of fluorescence.
• A single dose of TA-loaded hydrogel effectively reduced arthritis activity in mice, outperforming free TA injections.

Conclusions:

• The developed flare-responsive hydrogel represents a significant advancement in local drug delivery for inflammatory arthritis.
• This innovative system offers a potential next-generation therapeutic approach by titrating drug release to disease activity, improving IA management.